How pharma companies can make sure their corporate strategy in ESG is appealing to younger generations—and aligns with the issues this large segment of sustainability investors care about most.
Terry Branstad
Advertisement
Articles by Terry Branstad
Advertisement
Latest Updated Articles
Elevating ESG Message: Today’s Modern Investor is KeyPublished: August 17th 2022 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
WHO Finalizes United States’ Withdrawal from Organization: Report
2
JP Morgan 2026 Wrap Up: Pharma Leaders Speak About the Conference and the State of the Industry
3
Novavax Enters $530 Million License Agreement with Pfizer for Vaccine Development
4
Janux Therapeutics Enters $850 Million Collaboration and Exclusive License Agreement with Bristol Myers Squibb to Develop Tumor-Activated Therapeutics
5